265 related articles for article (PubMed ID: 7332041)
1. Do have antidepressants of the second generation anxiolytic properties?
Kabes J; Dostal T; Balon R
Agressologie; 1981 Nov; 22(E):11-3. PubMed ID: 7332041
[No Abstract] [Full Text] [Related]
2. [A profile of the clinical effectiveness of second generation antidepressive agents].
Kabes J; Dostal T; Balon R; Papezová H
Cesk Psychiatr; 1984 Feb; 80(1):12-20. PubMed ID: 6697402
[No Abstract] [Full Text] [Related]
3. Intraindividual comparison of the antidepressant effectivity of viloxazine and maprotiline.
Dostal T; Kabes J
Act Nerv Super (Praha); 1978 Dec; 20(4):252-3. PubMed ID: 735720
[No Abstract] [Full Text] [Related]
4. [Third-generation antidepressive agents. Experience with 100 cases of primary depression treated with viloxazine, nomifensine and mianserin].
Faravelli C; Tonini R; Zaccara G; Marchetti G
Minerva Psichiatr; 1981; 22(2):79-83. PubMed ID: 7266323
[No Abstract] [Full Text] [Related]
5. [Comparative results of the treatment of anxiety in the depressive syndrome with Tolvon, Vivalan and Alival].
Ivanov V; Popov G
Agressologie; 1981 Nov; 22(D):29-30. PubMed ID: 7332038
[No Abstract] [Full Text] [Related]
6. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
Laakmann G
Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
[No Abstract] [Full Text] [Related]
7. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
Lomas DM
J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
[TBL] [Abstract][Full Text] [Related]
8. Nomifensine and maprotiline in endogenous depression: comparative efficacy and side effects.
Levin A
Int Pharmacopsychiatry; 1982; 17 Suppl 1():89-96. PubMed ID: 6752081
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of nomifensine, maprotiline and imipramine in a double-blind study of patients with endogenous depression].
Faltus F; Filip V; Karen P; Kolomazník M; Korínková V; Libiger J; Molcan J; Zapletálek M; Zizka V
Cesk Psychiatr; 1986 Apr; 82(2):131-8. PubMed ID: 3524870
[No Abstract] [Full Text] [Related]
10. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
[No Abstract] [Full Text] [Related]
11. [The effect of maprotiline on target symptoms of depressive states].
Faltus F
Act Nerv Super (Praha); 1982 May; 24(2):99-100. PubMed ID: 7102230
[No Abstract] [Full Text] [Related]
12. Clinical experience with maprotiline.
Kabes J; Dostal T; Roth Z
Act Nerv Super (Praha); 1982 May; 24(2):93-8. PubMed ID: 7048837
[No Abstract] [Full Text] [Related]
13. Maprotiline versus imipramine and placebo in neurotic depression.
van der Velde CD
J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
[TBL] [Abstract][Full Text] [Related]
14. [Further clinical experiences with maprotiline in endogeneous depressions].
Náhunek K; Svestka J; Rysánek R; Cesková E
Act Nerv Super (Praha); 1982 May; 24(2):81-7. PubMed ID: 7048835
[No Abstract] [Full Text] [Related]
15. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
Poelinger W; Haber H
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
[No Abstract] [Full Text] [Related]
16. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
[TBL] [Abstract][Full Text] [Related]
17. [Maprotiline in psychiatric ambulatory care].
Vinar O
Act Nerv Super (Praha); 1982 May; 24(2):112-8. PubMed ID: 7102223
[No Abstract] [Full Text] [Related]
18. [Comparative evaluation of the therapeutic efficacy of the antidepressants adepren, linamiphen and emovit].
Guliamov MG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):582-7. PubMed ID: 3716711
[TBL] [Abstract][Full Text] [Related]
19. [Comparative clinical study of the association of chlordiazepoxide-amitriptyline and maprotiline in patients suffering from depression with anxiety components].
Tsaras G; Ambrus J
Rev Med Suisse Romande; 1981 Jun; 101(6):483-6. PubMed ID: 7029696
[No Abstract] [Full Text] [Related]
20. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
